
ColonAI
Medical device company that develops AI-enabled solutions for colorectal cancer screening.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | €0.0 | round |
investor | €0.0 | round | |
investor | €0.0 | round | |
$30.0k | Grant | ||
Total Funding | 000k |
Related Content
Colonai is a software company leveraging artificial intelligence to assist gastroenterologists—physicians specializing in digestive system diseases—in the efficient screening, detection, and treatment of tumors during colonoscopy and wireless capsule endoscopy. The company operates in the healthcare technology market, specifically targeting medical professionals and healthcare institutions that perform gastrointestinal diagnostics. Colonai's business model revolves around providing advanced AI solutions that integrate seamlessly with existing medical equipment, enhancing the accuracy and efficiency of tumor detection. The company generates revenue through software licensing and subscription fees, offering its clients a cost-effective way to improve diagnostic outcomes and patient care. By focusing on AI-driven innovations, Colonai aims to set new standards in medical diagnostics, contributing to early detection and better treatment of gastrointestinal diseases.
Keywords: AI, gastroenterology, tumor detection, colonoscopy, capsule endoscopy, healthcare technology, medical diagnostics, software licensing, subscription model, patient care.